EP 0651642 A1 19950510 - USE OF 1,3-DICYCLOPROPYMETHYL-8-AMINO-XANTHINE FOR THE TREATMENT AND PREVENTION OF TYPE II DIABETES MELLITUS AND OBESITY.
Title (en)
USE OF 1,3-DICYCLOPROPYMETHYL-8-AMINO-XANTHINE FOR THE TREATMENT AND PREVENTION OF TYPE II DIABETES MELLITUS AND OBESITY.
Title (de)
VERWENDUNG VON 1,3-DICYCLOPROPYLMETHYL-8-AMINO-XANTHIN ZUR BEHANDLUNG UND VORBEUGUNG DES DIABETES MELLITUS TYP II UND DER FETTLEIBIGKEIT.
Title (fr)
UTILISATION DE 1,3-DICYCLOPROPYMETHYL-8-AMINO-XANTHINE POUR LE TRAITEMENT ET LA PREVENTION DU DIABETE SUCRE DE TYPE II ET DE L'OBESITE.
Publication
Application
Priority
- GB 9301539 W 19930721
- GB 9215633 A 19920723
Abstract (en)
[origin: WO9402150A1] A method for the treatment and/or prophylaxis of obesity or for the treatment of Type II diabetes in mammals, such as humans, which comprises administering to the mammal in need of such treatment and/or prophylaxis an effective and/or prophylactic, non-toxic amount of Compound 1 (1,3-dicyclopropymethyl-8-amino-xanthine).
IPC 1-7
IPC 8 full level
C07D 473/06 (2006.01); A61K 31/52 (2006.01); A61K 31/522 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01)
CPC (source: EP)
A61K 31/52 (2013.01); A61P 3/08 (2017.12); A61P 3/10 (2017.12)
Citation (search report)
See references of WO 9402150A1
Designated contracting state (EPC)
BE CH DE FR GB IE IT LI NL
DOCDB simple family (publication)
WO 9402150 A1 19940203; AU 4714393 A 19940214; CN 1043610 C 19990616; CN 1114880 A 19960117; EP 0651642 A1 19950510; GB 9215633 D0 19920909; JP H07509456 A 19951019; MX 9304435 A 19940429; TW 258663 B 19951001; ZA 935339 B 19950118
DOCDB simple family (application)
GB 9301539 W 19930721; AU 4714393 A 19930721; CN 93116874 A 19930722; EP 93917883 A 19930721; GB 9215633 A 19920723; JP 50429494 A 19930721; MX 9304435 A 19930722; TW 82105967 A 19930727; ZA 935339 A 19930723